menu icon
Coronavirus (COVID-19) Latest news

Different course options

Full time | University of Strathclyde | 12 months | SEP-21

Study mode

Full time

Duration

12 months

Start date

SEP-21

Key information
DATA SOURCE : IDP Connect

Qualification type

MSc - Master of Science

Subject areas

Medicine (General) Biomedical Sciences

Course type

Taught

Course Summary

The MSc in Cancer Therapies is unique in the UK. ?It's a multifaceted course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology.? You'll also get an understanding of the practical, ethical and economic implications of personalised cancer therapy.? The degree is for graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies.

You'll be taught in the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK?. The Institute has major facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit - the only one of its kind in the UK. You'll therefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas.

Studying with us will provide you with the skills to access, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade - from target evaluation and engagement to clinical trials. The course will also provide you with the specialist research training and a breadth of skills needed for your future career. The master’s degree has been designed in response to a growing demand from academia, industry and health care providers for a course which focuses on current and emerging cancer therapies, in a format which covers essential multidisciplinary aspects of the topic.

Modules

Radiotherapy is used in the management of over 50% of patients with cancer and most new cancer therapies are introduced in combination with radiotherapy. Using a mix of lectures and workshops you'll gain an understanding of the current clinical modes of radiotherapy and the emerging technologies most likely to provide the next generation of radiotherapy methods such as proton and radiopharmaceutical therapies. You'll gain an understanding of the cellular effect of radiation including the strengths and limitation of different radiation methods and the use of nuclear medicine in therapy and diagnosis. The class will also provide a working knowledge of the mechanism and potential therapeutic use of combination treatment with radiation and chemotherapy or other therapeutic methods such as nanoparticles and biological therapies.

Tuition fees

UK fees
Course fees for UK students

For this course (per year)

£8,500

Average for all Postgrad courses (per year)

£5,202

International fees
Course fees for non-UK/ international students

For this course (per year)

£21,300

Average for all Postgrad courses (per year)

£12,227

Entry requirements

Minimum second class honours degree or international equivalent in a science or health related subject. Students with alternative entry standards or professional experience may also be considered and are usually admitted in the first instance to the diploma course. Upon satisfactory completion of all semester 1 assessment, these students will be offered the chance to transfer to the MSc programme.

University information

The University of Strathclyde is transforming its learning environment to offer its growing student population a first-class institution experience in which to develop, learn and socialise. Welcoming students from across the globe, the university offers a diverse range of courses. The university is committed to offering students the best possible education. The past few years have seen substantial investment in upgrading and creating new...more

Similar courses at this uni